The Heart Centre, Rigshospitalet, Copenhagen, Denmark.
Department of Cardiology, Copenhagen University Hospital Herlev and Gentofte, Copenhagen, Denmark; Department of Cardiology, Bispebjerg Hospital, Copenhagen, Denmark.
Int J Cardiol. 2019 Oct 15;293:67-72. doi: 10.1016/j.ijcard.2019.06.059. Epub 2019 Jun 22.
Little is known about the subsequent risk of stroke and recurrence of IE for patients surviving infective endocarditis (IE) with a residual vegetation at discharge.
Patients were consecutively included in the East Danish Endocarditis Registry from 2002 to 2012. We included patients undergoing medical treatment only during IE admission who were discharged alive. Size of residual vegetation was assessed by echocardiography at discharge and patients were categorized according to median length of residual vegetation. Using multivariable adjusted Cox Proportional hazard analysis, we assessed the associated risk of stroke and recurrence of IE between study groups.
Among 915 IE patients, 305 were included after selection criteria were applied, 151 patients without residual vegetation, 73 patients with 1-5 mm residual vegetation, and 81 patients with >5 mm residual vegetation. We identified an increased associated risk of stroke for patients with 1-5 mm and > 5 mm residual vegetation, HR = 0.88 (95% CI: 0.26-2.94) and HR = 2.95 (95% CI:1.18-7.34) compared with patients without residual vegetation. No difference was seen between groups for the associated risk of recurrence of IE, HR = 1.39 (95% CI: 0.91-2.13) and HR = 1.38 (95% CI: 0.91-2.10) for patients with a residual vegetation 1-5 mm and > 5 mm compared with patients without residual vegetation.
Patients surviving IE with a residual vegetation > 5 mm had an increased associated risk of stroke compared with patients without residual vegetation. These findings provide new perspectives on a patient group sparsely describe, suggesting a potential benefit of therapy among patients surviving IE with a residual vegetation > 5 mm.
对于患有感染性心内膜炎(IE)并在出院时残留赘生物的患者,人们对其中风和 IE 复发的后续风险知之甚少。
2002 年至 2012 年,患者连续被纳入丹麦东部心内膜炎注册研究。我们纳入了仅在 IE 住院期间接受治疗并存活出院的患者。出院时通过超声心动图评估残留赘生物的大小,并根据残留赘生物的中位数长度对患者进行分类。使用多变量调整的 Cox 比例风险分析,我们评估了研究组之间中风和 IE 复发的相关风险。
在 915 例 IE 患者中,应用选择标准后有 305 例患者入选,其中 151 例无残留赘生物,73 例有 1-5mm 残留赘生物,81 例有>5mm 残留赘生物。我们发现,与无残留赘生物的患者相比,1-5mm 和>5mm 残留赘生物的患者中风的相关风险增加,HR=0.88(95%CI:0.26-2.94)和 HR=2.95(95%CI:1.18-7.34)。然而,各组 IE 复发的相关风险无差异,HR=1.39(95%CI:0.91-2.13)和 HR=1.38(95%CI:0.91-2.10),与无残留赘生物的患者相比,残留赘生物为 1-5mm 和>5mm 的患者。
患有>5mm 残留赘生物的 IE 存活患者中风的相关风险增加,与无残留赘生物的患者相比。这些发现为这一描述甚少的患者群体提供了新的视角,表明在患有>5mm 残留赘生物的 IE 存活患者中,治疗可能具有潜在益处。